Search research articles
Contact Us
Filters
Showing results (251-260 of 283) with videos related to
Page
of 29
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 17, 2020
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era
Sarah Schmidt, Ying Liu, Zhen-Huan Hu, et al.
Cancer
|
September 23, 2020
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States
Talha Badar, Parameswaran Hari, Omar Dávila, et al.
Cancer
|
April 13, 2018
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure
Sonali M Smith, James Godfrey, Kwang Woo Ahn, et al.
Cancer Research Communications
|
March 27, 2023
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis
Lijun Yao, Reyka G Jayasinghe, Brian H Lee, et al.
Blood Cancer Discovery
|
December 9, 2025
Longitudinal profiling of tumor and immune compartments uncovers patterns of dysregulation and associations with response in multiple myeloma
Denis J Ohlstrom, William C Pilcher, Marina E Michaud, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 5, 2013
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission
Erica D Warlick, Kristjan Paulson, Ruta Brazauskas, et al.
The New England Journal of Medicine
|
May 11, 2012
Lenalidomide after stem-cell transplantation for multiple myeloma
Philip L McCarthy, Kouros Owzar, Craig C Hofmeister, et al.
The Lancet. Haematology
|
August 23, 2017
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial
Sarah A Holstein, Sin-Ho Jung, Paul G Richardson, et al.
Haematologica
|
April 21, 2022
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis
Matthew Mei, Raju Pillai, Soyoung Kim, et al.
The New England Journal of Medicine
|
December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
John S Welch, Allegra A Petti, Christopher A Miller, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 283) with videos related to
Sort By:
Page
of 29
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 17, 2020
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era
Sarah Schmidt, Ying Liu, Zhen-Huan Hu, et al.
Cancer
|
September 23, 2020
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States
Talha Badar, Parameswaran Hari, Omar Dávila, et al.
Cancer
|
April 13, 2018
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure
Sonali M Smith, James Godfrey, Kwang Woo Ahn, et al.
Cancer Research Communications
|
March 27, 2023
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis
Lijun Yao, Reyka G Jayasinghe, Brian H Lee, et al.
Blood Cancer Discovery
|
December 9, 2025
Longitudinal profiling of tumor and immune compartments uncovers patterns of dysregulation and associations with response in multiple myeloma
Denis J Ohlstrom, William C Pilcher, Marina E Michaud, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 5, 2013
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission
Erica D Warlick, Kristjan Paulson, Ruta Brazauskas, et al.
The New England Journal of Medicine
|
May 11, 2012
Lenalidomide after stem-cell transplantation for multiple myeloma
Philip L McCarthy, Kouros Owzar, Craig C Hofmeister, et al.
The Lancet. Haematology
|
August 23, 2017
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial
Sarah A Holstein, Sin-Ho Jung, Paul G Richardson, et al.
Haematologica
|
April 21, 2022
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis
Matthew Mei, Raju Pillai, Soyoung Kim, et al.
The New England Journal of Medicine
|
December 14, 2016
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
John S Welch, Allegra A Petti, Christopher A Miller, et al.
Page
of 29